Shanghai Omni Pharmaceutical Co., Ltd Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2011

Location

Shanghai China

Primary Industry

Pharmaceuticals

About

Established in 2011 and based in Shanghai, China, Shanghai Omni Pharmaceutical Co., Ltd operates as an innovative pharmaceutical company that focuses on the development of respiratory preparation. The company has a proprietary design platform incorporating breathing apparatus. The company's marketing network includes hospitals, retail pharmacies and e-commerce platforms. Kai Zhang, the chairman of the company, was formerly the director of product development at IVAX Corporation. In November 2024, Shanghai Omni Pharmaceutical Co., Ltd closed a series D+ funding. The company's main business is respiratory drug delivery technology and innovative drug research and development. Products include metered dose inhaler, dry powder inhaler, inhaled nebulizing solutions and nasal spry. The dry powder formulation project has been designated the National Key Science and Technology project, and received government support. Also, other projects have entered the clinical trial stage. Products can treat asthma and chronic obstructive pneumonia (COPD). The company generates revenue by providing respiratory preparation and related products.

Current Investors

Kleiner Perkins, Lilly Asia Ventures, 5Y Capital

Request a demo to show more

Primary Industry

Pharmaceuticals

Sub Industries

Healthcare, Pharmaceuticals

Website

www.omni-pharma.com

Verticals

HealthTech

Company Stage

Series D

Total Amount Raised

Subscriber access only

Key Contacts

Name	Position	Start Date	End Date	Vcard	Bio
	Chief Executive Officer						BM
	Chief Executive Officer & General Manager						BM

BM Board Member

Name	Firm	Deal Date	Number Of Deals	Vcard
						AI LP
						AI LP

AI Active Investor LP Lead Provider

Want to see more?

Request a demo for full access to this profile.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.